Lin, Chun-Hsien
Ovbiagele, Bruce
Liebeskind, David S.
Saver, Jeffrey L.
Lee, Meng http://orcid.org/0000-0002-7491-0571
Funding for this research was provided by:
National Science and Technology Council (MOST 108-2314-B-182-017, 109-2314-B-182-033-, MOST 110-2314-B-182-036 -MY2)
Chang Gung Memorial Hospital (CMRPG6H0191, CMRPG6H0441)
Article History
Received: 14 August 2023
Accepted: 24 February 2024
First Online: 1 March 2024
Compliance with ethical standards
:
: Dr. Saver reported being an employee of the University of California, which has patent rights in retrieval devices for stroke. The University of California received payments on the basis of clinical trial contracts for the number of participants enrolled in multicenter clinical trials sponsored by Medtronic, Stryker, Cerenovus, BrainsGate, NONO Inc., and Boehringer Ingelheim (prevention only). The University of California receives grant support from the National Institutes of Health (NIH) for Dr. Saver’s service in leadership roles in the National Institute of Neurological Disorders and Stroke StrokeNet national clinical trial network and from Diffusion Pharma for Dr. Saver’s leadership role in the PHAST-TSC multicenter trial. Dr. Saver reported serving as an unpaid consultant to Genentech advising on the design and conduct of the PRISMS trial; neither the University of California nor Dr. Saver received any payments for this voluntary service. Dr. Saver paid for his own travel. Dr. Saver reported receiving contracted hourly payments and travel reimbursement for services as a scientific consultant advising on rigorous trial design and conduct to Medtronic, Stryker, Cerenovus, BrainsGate, Boehringer Ingelheim (prevention only), NONO Inc., BrainQ, and Abbott; contracted stock options for services as a scientific consultant advising on rigorous trial design and conduct to Rapid Medical; and personal fees from Johnson & Johnson and Novo Nordisk. Other authors have no disclosure or conflict of interest.
: This study was a meta-analysis of published papers and did not need IRB or ethic committee approval.
: This study was a meta-analysis of published papers and did not enroll patients and therefore did not need informed consent.